Grifols (GIKLY) Tax Provisions (2010 - 2023)
Grifols (GIKLY) reported Tax Provisions of $46640.9 for Q4 2023, down 49.27% on a YoY basis from $91935.5 in Q4 2022, and down 49.27% quarter-over-quarter from $91935.5 in Q4 2022.
Grifols (GIKLY) Tax Provisions (2010 - 2023) Analysis & Trends
Grifols has reported Tax Provisions for 11 years, with the latest figure at $46640.9 in Q4 2023.
- For the quarter ending Q4 2023, Tax Provisions fell 49.27% year-over-year to $46640.9; the trailing twelve-month figure through Dec 2023 stood at -$176.1 million (up 15.59% YoY), and the FY2025 full-year result was $133.9 million, down 45.77% from the prior year.
- Tax Provisions for Q4 2023 stood at $46640.9, down from $91935.5 in the prior quarter.
- The five-year high for Tax Provisions was $91935.5 in Q4 2022, with the low at -$123.5 million in Q4 2019.
- Historically, Tax Provisions has averaged -$41.7 million across 4 years, with a median of -$32.5 million in 2019.
- Annual changes were most pronounced in 2019 — Tax Provisions grew 26.71% — and 2020, when it plunged 62.27%.
- Grifols' Tax Provisions stood at -$123.5 million in 2019, then surged by 57.34% to -$52.7 million in 2020, then surged by 100.17% to $91935.5 in 2022, then slumped by 49.27% to $46640.9 in 2023.
- The last three Tax Provisions figures came in at $46640.9 (Q4 2023), $91935.5 (Q4 2022), and -$52.7 million (Q1 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -411.19 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 1.45 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 755.00 Mn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 342.00 Mn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 709.00 Mn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 265.00 Mn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 559.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 461.00 Mn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 561.00 Mn |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 46,640.92 |
| Dec 31, 2022 | 91,935.51 |
| Mar 31, 2020 | -52.70 Mn |
| Dec 31, 2019 | -123.53 Mn |
| Mar 31, 2019 | -32.47 Mn |
| Dec 31, 2018 | -134.97 Mn |
| Jun 30, 2018 | 51.77 Mn |
| Mar 31, 2018 | -44.31 Mn |
| Dec 31, 2017 | -187.58 Mn |
| Jun 30, 2017 | 58.41 Mn |
| Mar 31, 2017 | -52.70 Mn |
| Dec 31, 2016 | 307.28 Mn |
| Sep 30, 2016 | 39.35 Mn |
| Jun 30, 2016 | 47.12 Mn |
| Dec 31, 2015 | 46.62 Mn |
| Sep 30, 2015 | 47.58 Mn |
| Jun 30, 2015 | 43.68 Mn |
| Mar 31, 2015 | -38.39 Mn |
| Dec 31, 2012 | -35.68 Mn |
| Sep 30, 2012 | 42.71 Mn |